Read + Share
Amedeo Smart
Independent Medical Education
Yang S, Wu S, Zhao Y, Chen G, et al. Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies. Lung Cancer 2023;180:107194.PMID: 37163774
Email
LinkedIn
Facebook
Twitter
Privacy Policy